Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer

Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer

Saved in:
Bibliographic Details
Main Authors: Karen A. Autio, Deaglan J. McHugh, Dana E. Rathkopf, Han Xiao, Swathi Merugu, Phillip Wong, Mehrin Jan, Tanya B. Dorff, Elisabeth I. Heath, Howard I. Scher
Format: Article
Language:English
Published: Innovative Healthcare Institute 2025-04-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
adt
biochemical recurrence
immunotherapy
parp inhibitor
prostate cancer
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-24-36
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2666-2345
2590-017X

Similar Items